SILK ROAD MEDICAL, INC.

SILKUnited States

23 filed reports · 332 financial concepts

Latest figures

Group totals as stated in the company’s own filed reports, each with a link to its report. The change is against the same period a year earlier.

Latest fiscal year

Revenue

$177M

FY2023 · to Dec 31, 2023

up +27.8% vs $139M

10-K

Net income

-$55.7M

FY2023 · to Dec 31, 2023

a year earlier: -$55M

10-K

Operating income

-$59.3M

FY2023 · to Dec 31, 2023

a year earlier: -$52M

10-K

Latest quarter

Revenue

$51.2M

Q2 FY2024 · to Jun 30, 2024

up +13.1% vs $45.3M

10-Q

Net income

-$16.6M

Q2 FY2024 · to Jun 30, 2024

a year earlier: -$13.5M

10-Q

Operating income

-$17.2M

Q2 FY2024 · to Jun 30, 2024

a year earlier: -$14.3M

10-Q

Filed reports

23 reports · Mar 2019 to Jun 2024

Each report counts once it has at least one extracted financial fact.

Report typeReportsFactsPeriods
Quarterly · 10-QSEC EDGAR172,922Mar 2019 to Jun 2024
Annual · 10-KSEC EDGAR52,137Dec 2019 to Dec 2023
Registration · S-1SEC EDGAR1299Aug 2019

Documents

PeriodTypePeriod endPublishedFactsSource
FY2024 Q210-Q2024-06-302024-08-07343Open
FY2024 Q110-Q2024-03-312024-05-07195Open
FY202310-K2023-12-312024-02-28681Open
FY2023 Q310-Q2023-09-302023-11-08215Open
FY2023 Q210-Q2023-06-302023-08-08148Open
FY2023 Q110-Q2023-03-312023-05-09150Open
FY202210-K2022-12-312023-02-28353Open
FY2022 Q310-Q2022-09-302022-11-09163Open
FY2022 Q210-Q2022-06-302022-08-09139Open
FY2022 Q110-Q2022-03-312022-05-10140Open
FY202110-K2021-12-312022-03-01378Open
FY2021 Q310-Q2021-09-302021-11-09155Open

Financial data

332 concepts · 5,358 facts

Each concept is one reported line item or metric. The count is how many values of it are held, across the periods shown.

Financial332 concepts · 5,358 facts · Dec 2016 to Jun 2024

  • Cash cash equivalents restricted cash and restricted cash equivalents37 · Dec 2016 to Jun 2024
  • Stockholders equity (US GAAP)37 · Dec 2016 to Jun 2024
  • Share based compensation arrangement by share based payment award options outstanding intrinsic value34 · Dec 2016 to Jun 2024
  • Share based compensation arrangement by share based payment award options outstanding number34 · Dec 2016 to Jun 2024
  • Share based compensation arrangement by share based payment award options outstanding weighted average exercise price34 · Dec 2016 to Jun 2024
  • Adjustments to additional paid in capital share based compensation employee stock purchase program requisite service period recognition33 · Dec 2017 to Jun 2024
  • Allocated share based compensation expense33 · Dec 2017 to Jun 2024
  • Amortization of financing costs and discounts33 · Dec 2017 to Jun 2024
  • Capital expenditures incurred but not yet paid33 · Dec 2017 to Jun 2024
  • Cash cash equivalents restricted cash and restricted cash equivalents period increase decrease including exchange rate effect33 · Dec 2017 to Jun 2024
  • Comprehensive income net of tax33 · Dec 2017 to Jun 2024
  • Cost of goods and services sold (US GAAP)33 · Dec 2017 to Jun 2024
  • Gross profit (US GAAP)33 · Dec 2017 to Jun 2024
  • Increase decrease in accounts payable33 · Dec 2017 to Jun 2024
  • Increase decrease in accounts receivable33 · Dec 2017 to Jun 2024
  • Increase decrease in accrued liabilities33 · Dec 2017 to Jun 2024
  • Increase decrease in inventories33 · Dec 2017 to Jun 2024
  • Increase decrease in other noncurrent assets33 · Dec 2017 to Jun 2024
  • Increase decrease in other operating liabilities33 · Dec 2017 to Jun 2024
  • Increase decrease in prepaid deferred expense and other assets33 · Dec 2017 to Jun 2024
  • Interest expense (US GAAP)33 · Dec 2017 to Jun 2024
  • Interest paid net33 · Dec 2017 to Jun 2024
  • Inventory write down33 · Dec 2017 to Jun 2024
  • Investment income interest33 · Dec 2017 to Jun 2024

Segments

Figures broken down by business line, region, product or another axis the company reports on.

No segment breakdowns.

Text from filings

Management commentary and risk factors, extracted from SEC filings only.

No commentary or risk-factor text for this company.

Earnings calls

Transcripts with management claims and analyst questions, one per fiscal period.

No earnings-call transcripts for this company.

Executive media

Podcasts, interviews and conference appearances by the company's executives, with their claims.

No media appearances for this company.

Ask about this company in your AI model

Connect FactIQ to Claude, ChatGPT or another AI model (how to install), then paste this prompt.

Use FactIQ to get the revenue, net income and operating income of SILK ROAD MEDICAL, INC. (SILK) from its filed reports, for the last five fiscal years and the latest quarter or half year. Link each figure to its filing, and chart the trend.

Works once FactIQ is connected

Reports are counted as filed reports with at least one served fact. Counts are read from the database (last read Nov 19, 2026) and refreshed every few hours.